Newsfeeds - Spark Newswire

2 minute read

Jazz Pharmaceuticals Begins Enrollment For Clinical Trial To Evaluate JZP150 For Adults With PTSD

Today, 12:10 PM

Biopharmaceutical company Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced Thursday that it has enrolled the first patient in its Phase 2 clinical trial evaluating the safety and efficacy of JZP150, an investigational first-in-class small molecule for the treatment of adults with p

JAZZ

2 minute read

Jazz Pharmaceuticals: Debt Overview

By Benzinga Insights

Today, 12:10 PM

Shares of Jazz Pharmaceuticals (NASDAQ:JAZZ) rose by 0.8% on Wednesday. Before having a look at the importance of debt, let us look at how much debt Jazz Pharmaceuticals has.

JAZZ

2 minute read

Jazz Pharmaceuticals Announces First Patient Enrolled In Phase 2 Clinical Trial Evaluating JZP150 For Once-Daily Treatment Of Adults With Post-Traumatic Stress Disorder

By Benzinga Newsdesk

Today, 12:10 PM

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) today announced that the first patient has been enrolled in a Phase 2 clinical trial evaluating the safety and efficacy of JZP150, an investigational first-in-class small

JAZZ

7 minute read

Corporate Cannabis Takeover? Assessing 5 Big Industries Already At The Table

By The Bluntness

Today, 12:10 PM

This article was originally published on The Bluntness, and appears here with permission. As more big business movers and shakers appear to be ratcheting up their incursions into the cannabis industry, industry advocates are stepping up their defense.

AVCNF

1 minute read

10 Biggest Price Target Changes For Monday

By Lisa Levin

Today, 12:10 PM

JP Morgan raised the price target on Public Storage (NYSE: PSA) from $359 to $385. Public Storage shares fell 0.2% to $361.00 in pre-market trading.

ANTM

11 minute read

The Week In Cannabis: Pfizer, Visa, $730M+ In Financings, Malta, EU, Columbia Care, MedMen, Uruguay And More

By Javier Hasse

Today, 12:10 PM

Below is a recap of the main news related to the cannabis industry and markets for the week of December 13, 2021. Contents

ACRDF

1 minute read

10 Biggest Price Target Changes For Friday

By Lisa Levin

Today, 12:10 PM

Piper Sandler boosted Accenture plc (NYSE: ACN) price target from $354 to $433. Accenture shares dropped 0.4% to $399.00 in pre-market trading.

ACN

1 minute read

Needham Maintains Buy on Jazz Pharmaceuticals, Lowers Price Target to $215

By Benzinga Newsdesk

Today, 12:10 PM

Needham analyst Ami Fadia maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and lowers the price target from $220 to $215.

JAZZ

1 minute read

Jazz Posts New Data for ALL/LBL Treatment At ASH 2021 Annual Meeting

By Vandana Singh

Today, 12:10 PM

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) revealed initial positive results from a Phase 2/3 trial of intramuscular (IM) administration of Rylaze (asparaginase erwinia…

JAZZ

2 minute read

FDA
News

PharmaMar, Jazz Pharmaceuticals Announced Initiation of Confirmatory Phase 3 Clinical Trial of Zepzelca (lurbinectedin) for the Treatment of Patients with Relapsed Small Cell Lung Cancer

By Charles Gross

Today, 12:10 PM

PharmaMar (MSE: PHM) and partner Jazz Pharmaceuticals plc (NASDAQ: JAZZ) today announced the initiation of a confirmatory Phase 3 clinical trial, LAGOON, evaluating Zepzelca® (lurbinectedin) for the treatment of patients with relapsed small cell lung cancer (SCLC).

JAZZ